StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)

Close on Nov 16, 2026Market cap $28.95MP/E –Yield –

Scynexis ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Scynexis's ebitda for the twelve months ending Dec 31, 2024 was -$37.12M, down 150.7% year over year. For fiscal 2024 it was -$37.12M, down 150.7% from the year before. The highest annual figure on record is $73.25M in fiscal 2023.

Annual ebitda

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$37.12M-150.7%
FY2023Dec 31, 2023$73.25M–
FY2022Dec 31, 2022-$85.15M–
FY2021Dec 31, 2021-$60.46M–
FY2020Dec 31, 2020-$51.04M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$8.05M–
Q3 FY2024Sep 30, 2024-$10.32M–
Q2 FY2024Jun 30, 2024-$9.24M-107.9%
Q1 FY2024Mar 31, 2024-$9.51M–
Q4 FY2023Dec 31, 2023-$22.94M–
Q3 FY2023Sep 30, 2023-$9.95M–
Q2 FY2023Jun 30, 2023$116.67M–
Q1 FY2023Mar 31, 2023-$10.53M–
Q4 FY2022Dec 31, 2022-$22.33M–
Q3 FY2022Sep 30, 2022-$21.65M–
Q2 FY2022Jun 30, 2022-$21.59M–
Q1 FY2022Mar 31, 2022-$19.58M–
Q4 FY2021Dec 31, 2021-$22.05M–
Q3 FY2021Sep 30, 2021-$19.39M–
Q2 FY2021Jun 30, 2021-$17.45M–
Q1 FY2021Mar 31, 2021-$1.57M–

More Scynexis figures

See a number that looks wrong?